Patent application number | Description | Published |
20120066194 | APPROXIMATE REPRESENTATION AND PROCESSING OF ARBITRARY CORRELATION STRUCTURES FOR CORRELATION HANDLING IN DATABASES - Implementations of the present disclosure include receiving user input, the user input indicating a distribution type and a correlation factor, providing the distribution type and correlation factor for identifying an approximate correlation representation (ACR) histogram from a plurality of ACR histograms based on the distribution type and the correlation factor, receiving the ACR histogram, retrieving a first distribution associated with a first uncertain value and a second distribution associated with a second uncertain value from computer-readable memory, processing the ACR histogram, the first distribution and the second distribution to generate a correlation histogram that represents a correlation between the first uncertain value and the second uncertain value, and displaying the correlation histogram on a display. | 03-15-2012 |
20130194271 | Visualization of Uncertain Times Series - Implementations of the present disclosure include methods, systems, and computer-readable storage mediums for receiving a probability distribution function model, the probability distribution function model representing an uncertain time series and providing a plurality of probability distribution functions, each probability distribution function corresponding to respective values at a respective time in the uncertain time series, generating a visualization based on the probability distribution function model to create a transparency gradient, the transparency gradient including a plurality of points graphically representing the plurality of probability distribution functions, and displaying the visualization including the transparency gradient, wherein a visual characteristic of each point of the plurality of points of the transparency gradient is a function of a probability of the respective value associated with the respective point. | 08-01-2013 |
Patent application number | Description | Published |
20090041844 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 02-12-2009 |
20090098202 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 04-16-2009 |
20090281153 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 11-12-2009 |
20100209506 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders. | 08-19-2010 |
20110014284 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders. | 01-20-2011 |
20110150994 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 06-23-2011 |
20110195122 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 08-11-2011 |
20110236477 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases. | 09-29-2011 |
20120282337 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 11-08-2012 |
20120282338 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 11-08-2012 |
20130274300 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 10-17-2013 |
20140335175 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 11-13-2014 |